http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CH-531529-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b172e4dc6f8b115773eb99a04e8260f6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D327-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D327-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-39
filingDate 1970-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d70d407670e1a9584459bb473d8dc64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_905d0959b9c4e92ef4b194172beea260
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29c501602cf3c05722b842ca5a32421c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a84c58230cbd39617271b5fb630dd203
publicationDate 1972-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CH-531529-A
titleOfInvention Process for the preparation of new 3-carboxy-1-thia-isochroman-1.1-dioxide derivatives
abstract Therapeutic intermediates exhibiting also anti-convulsive properties in animal experiments, consist of 3-carboxy-1-thia-isochroman-1,1-di oxide derivs. (I): (where R1 and R2 are lower alkyl and R3 is H or alkyl). Prepd. (a) by reacting cpds. (II): (where R4 is -COOH, carboxylate, carbamoyl or carbonitrile and Hal is halogen) with conc. H2SO4 at room temp., diluting and heating for example to 70-90 degrees C or (b) by saponifying 3-carbamoyl- or 3-carboxylate derivs. of (I) in diluted inorganic acids, such as HCl or H2SO4.
priorityDate 1969-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431922745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154104597
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12638927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12638963
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415204837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431951959
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465451746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12638930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11748202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465614591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426558366
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549007

Total number of triples: 36.